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Abstract
The paper published in the January 2015 issue of this journal by Gusmano and colleagues entitled “Shanghai rising: 
health improvements as measured by avoidable mortality since 2000” has spurred this commentary. We discuss 
controversial issues surrounding the concept of avoidable mortality in health service research in general and 
Gusmano’s study in particular. The impact of overall social development on mortality may be underappreciated in 
Gusmano’s report; the innovative efforts of healthcare professionals to use cutting-edge technology and evidence-
approved preventive strategies to reduce healthcare cost and improve the life quality of community members may 
not necessarily come to fruition in death reduction, and might be undervalued, too. More critically, the shape and 
magnitude of emerging health issues in Shanghai, such as accidents and injuries, pollution-related cancers, may be 
camouflaged in Gusmano’s report. We conclude this commentary by suggesting the most urgent questions to be 
addressed in the future studies. 
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The paper by Gusmano and colleagues in the January 2015 issue of this journal is interesting and provoking (1). It “examined the evolution of  Shanghai’s 
healthcare system” by analyzing “avoidable mortality over 
the period 2000–10 and compared Shanghai’s experience to 
other mega-city regions”. The main result was that: “the age-
adjusted rate of avoidable mortality, per 1,000 population(s), 
dropped from 0.72 to 0.50. The rate of decrease in age-adjusted 
avoidable mortality in Shanghai was comparable to New York 
City and Paris, but lower than London (42%)”. Gusmano et 
al. (1) concluded that: “establishment of the Municipal Center 
for Disease Control and Prevention and its upgrading of public 
health and health services are likely to have contributed to the 
large decrease in the number and rate of avoidable deaths”. We 
applaud the authors’ efforts to place Shanghai’s unprecedented 
rise in a unique comparative examination of top megacities in 
the world. However, we believe that Gusmano and colleagues’ 
interpretations of their results deserve further discussion. 
The chief concerns of Cusmano’s report are rooted in 
the unavoidable limitations of the concept of avoidable 
mortality. Created as a tool for medical audit by David 
Rutstein of Harvard Medical School in the 1970s (2), with 
various synonyms, the terms attracted considerable interest 
since then and have been used as measuring instruments to 
assess the quality of healthcare. The milestone application 
of avoidable mortality is the publication of the European 
Community Atlas of Avoidable Death in 1988 (3). The report 
concluded that avertable deaths were relatively common, and 
improvements of accessibility of healthcare had a measurable 
impact during the 1980s. The avoidable mortality, however, 
was much less sensitive to the improvement of healthcare 
services when avoidable mortality dropped below a certain 
level due to floor effects (4). Surprisingly, with a relatively 
high level of avoidable mortality in the early year, and 
approximately 50% decline in deaths from coronary heart 
disease from 1980 through 2000 (5), the United States (U.S) 
experienced a much smaller reduction of avoidable mortality 
during the same period according to Nolte et al. (6). 
The term of avoidable mortality has been used by the World 
Health Organization (WHO) (7), and researchers in many 
countries (8–21), mainly the countries of Organization for 
Economic Co-operation and Development (OECD). In spite 
of a steady increase in the number of publications using the 
term of avoidable mortality since the late 1980s, little progress 
has been made in advancing the original concept, critically 
limiting its’ acceptability among health serve research 
community (4,22). The concept of avoidable mortality 
failed to find its way to be widely used in the country where 
it originated. The most recent study applying the concept 
of avoidable mortality to examine healthcare service in the 
U.S. was actually performed by non-U.S. researchers for an 
international comparison (6). It is interesting to note that, 
very often, there were some researchers questioning the 
validity of a research paper immediately after it was published 
using the concept of “avoidable mortality”, from the early 
dialogue between Andreev et al. (23) and Holland (22), 
Alleyne (24) and Nolte et al. (6) to the recent debates between 
Allin and Grignon (25) and Lavergne and McGrail (26,27), 
and Peter et al.’ s commentary (28) on papers by Mackenbach 
et al. (29), and Schoenbaum et al. (30). This is phenomenal 
with scientific publications, highlighting a high level of 
enthusiasm in search for a simple metric to measure health 
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system performance and a growing dissatisfaction as well. 
The use of death as an endpoint and focusing on mortality 
are obvious limitations of the concept of avoidable mortality 
(4,22). There are likely to be many underlying reasons for 
an observed declining of amenable mortality. Interpretation 
of the data must go beyond the aggregate figure to look 
within populations if these findings are to inform policy. A 
substantial amount of disease burdens in modern society 
are disability-related social cost rather deaths, avoidable 
mortality fails to reflect the efforts that focus primarily on 
relieving pain and improving quality of life. Death is just the 
endpoint of a complex chain of events, and it is challenging if 
not impossible to clearly clarify which causes are avoidable. 
Most of the avoidable deaths should be partitioned into a 
proportion to which reductions are attributable, including 
primordial, primary, secondary, or tertiary preventive efforts. 
Additionally, emerging health issues, such as road injuries 
and mental health problems, create significant health burdens 
in the megacities. Large portions of the resources have been 
invested to respond to these ever-changing challenges with a 
limited impact on mortality but substantially on morbidity. 
After having comprehensively assessed the validity of 
avoidable mortality against the disease spectrum of modern 
society, Pérez et al. concluded in their recent report that: 
“avoidable mortality does not seem to appear to be a good 
indicator for analyzing the performance of healthcare systems” 
(p180) (28). 
With these limitations inherited, Gusmano et al.’s (1) report 
may under appreciate the impact of  overall social development 
on mortality. For example, Tuberculosis (TB) has been listed 
in almost all versions of avoidable death list, including the 
one used by Gusmano et al. However, the acquisition of TB is 
largely driven by socio-economic conditions (31,32). Simply 
attributing an outcome to a particular aspect of healthcare, 
such as consolidating multiple pre-existing institutions 
into one agency, is intrinsically arguable. Overstretching 
the connection between declining mortality from selected 
diseases and institutional reorganization or improvement 
of public health or healthcare services per se may divert 
resources from investment outside the healthcare system that 
more directly targets underlying causes. 
The innovative efforts of healthcare community in Shanghai 
in using cutting-edge technology and evidence-approved 
preventive strategies to improve the life quality of community 
members may be undervalued in Gusmano et al.’s report. 
Partnered with business communities, a regionally integrated 
health networks has been set up in Minghang of Shanghai, 
linking hospitals, community health centers, nursing 
homes and households to enhance early detection of non-
communicable disease using telemedicine and wireless 
technology (33). These efforts may not necessarily reduce 
mortality substantially but they dramatically reduce disability, 
increase independence and satisfaction with life for patients, 
and ultimately lower the emotional and financial cost to the 
family and society as a whole. More critically, the shape and 
magnitude of emerging health issues in Shanghai may be 
masked in Gusmano et al.’s report. There were 2,176 traffic 
accidents reported in Shanghai in the year 2010, resulting 
in 1,009 deaths (34), more than the death numbers from 
nephritis and nephrosis, malignancy of cervix and uterus, 
and pneumonia combined in Gusmano et al.’s report. 
Shanghai has the highest incidence of cancer in the nation 
(35). About 54,000 incident cases were reported in the year 
2013, representing an increase of 13% from 48,000 cases in 
the year 2011 (36). The dangerously high level of pollution is 
taking an increasingly devastating toll in Shanghai as well as 
other parts of China. Unfortunately, Gusmano et al.’s report 
failed to convey the sense of urgency and magnitude of these 
emerging issues. 
The novel contributions of Gusmano et al.’s work are the 
questions stimulated rather the answers offered. In addition 
to “the steep decline of avoidable mortality among Shanghai’s 
registered population”, the thought-provoking figure in 
Gusmano et al.’s report also clearly demonstrates that the 
same trends occurred in other megacities, and the avoidable 
mortality was plummeting in London. The Gusmano et al. (1) 
were correct that: “these city-level differences reflect the fact that 
avoidable mortality is influenced by a combination of population 
characteristics, socio-economic status” and “healthcare related 
variables related to health system performance”. Without 
examining these explanatory variables, in particular, health 
policy, spending and institutional reorganization, it might 
be disputable to jump to the conclusion that: “investments 
in public health infrastructure and increasing access to health 
services in megacities – both in China and worldwide – can 
produce significant mortality declines”. Comparisons beyond 
the mortality among four megacities in Gusmano et al.’s 
report would certainly generate robust conclusions. What 
were the factors driving the impressive decline of avoidable 
mortality in London, which was doing better than Shanghai 
as Gusmano et al. pointed out? A “comparable” decrease was 
also obtained in New York City. How much of the decline 
of avoidable mortality in New York City and London was 
attributed to revving-up health spending or institutional 
reorganization? Have mayor Bloomberg’s innovative public 
health policies, from cracking down on soda serving sizes 
to implementing a trans-fat ban in restaurants, added years 
to New Yorkers’ lives? Why Paris saw a slower-than-other 
decline? Where did Tokyo stand, one of the “big four”, and 
also sharing more similarities with Shanghai than anyone of 
the three cities included in Gusmano et al.’s study? Seeking 
the answers to these questions would greatly advance the 
Healthy Cities Movement globally. 
As the crown jewel of the Chinese economy, and one of the 
world’s most dynamic cities, Shanghai has been making a great 
stride in both health and overall social development in the 
past decades, offering a unique lens to scrutinize sustainable 
and scalable solutions to translate economic growth into 
better health. The wealth of the successful stories and costly 
lessons as well from Shanghai rising need to be systematically 
reviewed. Certainly, Cusmano et al.’s efforts are a part of this 
endeavor; they are to be congratulated for looking at Shanghai 
rising from a global health perspective.
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